VIVUS (VVUS) Resumes Trading +17%
Tweet
Share
E-mailGet Alerts VVUS Hot Sheet
Join SI Premium – FREE
Share of VIVUS Inc. (Nasdaq: VVUS) resume trading up 17% after the FDA approved obesity drug Qsymia.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Musk: will make the entire codebase of X open source
- SRX Global (SRXH) Halted, News Pending
- Lilly’s Retevmo approved by FDA for RET Tumors
Create E-mail Alert Related Categories
FDA, Momentum Movers, Trader Talk, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
